WASHINGTON TRUST Co reduced its stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO) by 5.1% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 222,974 shares of the company’s stock after selling 11,920 shares during the period. Thermo Fisher Scientific comprises approximately 2.3% of WASHINGTON TRUST Co’s holdings, making the stock its 5th largest position. WASHINGTON TRUST Co owned about 0.06% of Thermo Fisher Scientific worth $35,466,000 as of its most recent filing with the SEC.

Other institutional investors have also recently added to or reduced their stakes in the company. Panagora Asset Management Inc. increased its position in Thermo Fisher Scientific by 75.9% in the first quarter. Panagora Asset Management Inc. now owns 38,842 shares of the company’s stock valued at $5,500,000 after buying an additional 16,754 shares in the last quarter. Squarepoint Ops LLC purchased a new position in Thermo Fisher Scientific during the first quarter valued at $1,251,000. Ladenburg Thalmann Financial Services Inc. increased its position in Thermo Fisher Scientific by 0.7% in the first quarter. Ladenburg Thalmann Financial Services Inc. now owns 14,351 shares of the company’s stock valued at $2,031,000 after buying an additional 100 shares in the last quarter. First Republic Investment Management Inc. increased its position in Thermo Fisher Scientific by 4.5% in the first quarter. First Republic Investment Management Inc. now owns 78,599 shares of the company’s stock valued at $11,128,000 after buying an additional 3,397 shares in the last quarter. Finally, BlueMountain Capital Management LLC increased its position in Thermo Fisher Scientific by 53.5% in the first quarter. BlueMountain Capital Management LLC now owns 4,508 shares of the company’s stock valued at $638,000 after buying an additional 1,572 shares in the last quarter. 86.28% of the stock is owned by institutional investors.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Thermo Fisher Scientific Inc. (NYSE:TMO) traded down 2.97% during midday trading on Monday, hitting $139.90. The stock had a trading volume of 2,272,586 shares. Thermo Fisher Scientific Inc. has a one year low of $119.75 and a one year high of $160.68. The stock has a 50-day moving average price of $149.80 and a 200 day moving average price of $151.93. The firm has a market cap of $55.26 billion, a PE ratio of 27.96 and a beta of 1.24.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings results on Thursday, October 27th. The company reported $2.03 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.97 by $0.06. The business had revenue of $4.49 billion for the quarter, compared to the consensus estimate of $4.39 billion. Thermo Fisher Scientific had a return on equity of 14.95% and a net margin of 11.10%. The business’s revenue was up 8.9% on a year-over-year basis. During the same quarter last year, the business posted $1.80 EPS. On average, analysts predict that Thermo Fisher Scientific Inc. will post $8.25 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, January 16th. Shareholders of record on Thursday, December 15th will be paid a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a yield of 0.42%. The ex-dividend date of this dividend is Tuesday, December 13th. Thermo Fisher Scientific’s payout ratio is currently 12.00%.

TRADEMARK VIOLATION NOTICE: “WASHINGTON TRUST Co Has $35,466,000 Position in Thermo Fisher Scientific Inc. (TMO)” was posted by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are reading this article on another domain, it was illegally stolen and reposted in violation of US and international copyright & trademark laws. The original version of this article can be viewed at https://www.thecerbatgem.com/2016/11/28/washington-trust-co-has-35466000-position-in-thermo-fisher-scientific-inc-tmo.html.

Several equities analysts have weighed in on TMO shares. Zacks Investment Research raised Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $178.00 target price for the company in a research report on Monday, August 1st. Jefferies Group reissued a “hold” rating on shares of Thermo Fisher Scientific in a research report on Thursday, August 4th. Cleveland Research downgraded Thermo Fisher Scientific from a “buy” rating to a “neutral” rating in a research report on Friday, September 9th. JPMorgan Chase & Co. began coverage on Thermo Fisher Scientific in a research report on Thursday, September 22nd. They set an “overweight” rating and a $180.00 price objective for the company. Finally, Bank of America Corp. set a $180.00 price objective on Thermo Fisher Scientific and gave the stock a “buy” rating in a research report on Friday, October 7th. Two investment analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the stock. Thermo Fisher Scientific has an average rating of “Buy” and a consensus price target of $164.37.

In other news, CEO Marc N. Casper sold 30,000 shares of the business’s stock in a transaction on Thursday, September 1st. The stock was sold at an average price of $151.17, for a total value of $4,535,100.00. Following the sale, the chief executive officer now owns 308,647 shares of the company’s stock, valued at approximately $46,658,166.99. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Marc N. Casper sold 28,797 shares of the business’s stock in a transaction on Friday, September 2nd. The stock was sold at an average price of $151.01, for a total value of $4,348,634.97. Following the completion of the sale, the chief executive officer now directly owns 307,444 shares in the company, valued at approximately $46,427,118.44. The disclosure for this sale can be found here. Company insiders own 0.52% of the company’s stock.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

5 Day Chart for NYSE:TMO

Receive News & Stock Ratings for Thermo Fisher Scientific Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc. and related stocks with our FREE daily email newsletter.